HIV/AIDS Topics PopART Study Will Look at HIV Treatment as Prevention on a Population Level
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 01 October 2013 00:00
- Written by NIAID
A new clinical trial (HPTN 071), co-sponsored by the U.S. National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation, will assess whether offering HIV testing and early treatment on a door-to-door basis can help reduce incidence rates in Africa. The study -- which will involve 21 communities in South Africa and Zambia with a total population of 1.2 million -- is scheduled for completion in 2019.
ICAAC 2013: Tenofovir Vaginal Ring Protects Monkeys on Depo-Provera Against HIV-like Virus
- Details
- Category: HIV Prevention
- Published on Tuesday, 24 September 2013 00:00
- Written by Liz Highleyman
An intravaginal ring containing tenofovir protected all but 1 macaque monkey given hormonal contraceptives and repeatedly exposed to a hybrid human/simian virus similar to HIV, according to a late-breaker presentation at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) this month in Denver.
ICAAC 2013: Many Truvada PrEP Users Are Women and Young People, Survey Finds
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 13 September 2013 00:00
- Written by Gus Cairns
An analysis of nationally representative prescription data revealed that nearly half of people taking tenofovir/emtricitabine (Truvada) for pre-exposure prophylaxis (PrEP) are women, according to a poster presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) this week in Denver. The study also found that people using Truvada for HIV prevention were more likely to be under age 25 than those using it for treatment.
Coverage of 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Friday, 13 September 2013 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 53nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Denver, September 9-13, 2013.
Highlights of this year's meeting include experimental antiretroviral drugs and treatment strategies, CD4 cell gene therapy, HIV/HCV coinfection, liver transplants for people with HIV, and other sexually transmitted infections.
HIVandHepatitis.com ICAAC 2013 conference section
9/13/13
South African Study Confirms Adult Circumcision Reduces HIV Risk
- Details
- Category: HIV Prevention
- Published on Wednesday, 11 September 2013 00:00
- Written by Liz Highleyman
Large-scale implementation of voluntary adult male circumcision was associated with a significant reduction in rates of HIV infection in the South African town involved in the first ground-breaking circumcision for prevention study a decade ago, researchers reported in the in the open-access online journal PLoS Medicine.
Web Design and Development by